G L Kedderis

Improving Cancer Dose–Response Characterization by Using Physiologically Based Pharmacokinetic Modeling: An Analysis of Pooled Data for Acrylonitrile‐Induced Brain Tumors to Assess Cancer Potency in the Rat

M L Gargas, S M Hays, G. L. Kedderis, 2000, Risk analysis : an official publication of the Society for Risk Analysis.

Furan-induced cytolethality in isolated rat hepatocytes: correspondence with in vivo dosimetry.

G. L. Kedderis, M A Carfagna, G L Kedderis, 1993, Toxicology and applied pharmacology.

Furan-induced liver cell proliferation and apoptosis in female B6C3F1 mice.

G. L. Kedderis, R R Maronpot, R. Maronpot, 1997, Toxicology.

Pharmacokinetics in Early Drug Research

J B Houston, D A Smith, J H Fentem, 1997, Alternatives to laboratory animals : ATLA.

Prediction of furan pharmacokinetics from hepatocyte studies: comparison of bioactivation and hepatic dosimetry in rats, mice, and humans.

G. L. Kedderis, G L Kedderis, S D Held, 1996, Toxicology and applied pharmacology.

A physiologically based dosimetry description of acrylonitrile and cyanoethylene oxide in the rat.

M E Andersen, M L Gargas, G. L. Kedderis, 1995, Toxicology and applied pharmacology.

Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro.

M L Gargas, G. L. Kedderis, M. Gargas, 1993, Toxicology and applied pharmacology.

In vitro human tissue models in risk assessment: report of a consensus-building workshop.

J B Houston, G. L. Kedderis, K Krishnan, 2001, Toxicological sciences : an official journal of the Society of Toxicology.